William T. Clarke

414 total citations
19 papers, 309 citations indexed

About

William T. Clarke is a scholar working on Epidemiology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, William T. Clarke has authored 19 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 5 papers in Genetics and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in William T. Clarke's work include Inflammatory Bowel Disease (5 papers), Microscopic Colitis (4 papers) and Hepatitis B Virus Studies (3 papers). William T. Clarke is often cited by papers focused on Inflammatory Bowel Disease (5 papers), Microscopic Colitis (4 papers) and Hepatitis B Virus Studies (3 papers). William T. Clarke collaborates with scholars based in United States, United Kingdom and Canada. William T. Clarke's co-authors include Joseph D. Feuerstein, Peter Marks, Adam S. Cheifetz, Konstantinos Papamichael, Alan R. Spitzer, Jonathan M. Davis, William W. Fox, Benjamin Edwards, Kay E. Davies and Matthew Burgess and has published in prestigious journals such as Blood, Gastroenterology and Journal of Cell Science.

In The Last Decade

William T. Clarke

19 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William T. Clarke United States 10 91 91 70 54 52 19 309
Eunhee Han South Korea 11 65 0.7× 70 0.8× 119 1.7× 30 0.6× 42 0.8× 44 387
J.‐M. Otte Germany 8 108 1.2× 115 1.3× 172 2.5× 49 0.9× 77 1.5× 11 394
Rebecca Darlay United Kingdom 9 44 0.5× 51 0.6× 117 1.7× 19 0.4× 38 0.7× 19 305
Lysbeth ten Bloemendaal Netherlands 13 41 0.5× 101 1.1× 152 2.2× 52 1.0× 133 2.6× 22 337
Laure Bridoux Belgium 12 47 0.5× 44 0.5× 133 1.9× 15 0.3× 23 0.4× 23 257
Matthias Ross Germany 11 80 0.9× 100 1.1× 60 0.9× 81 1.5× 121 2.3× 15 411
Yanyan Hu China 12 82 0.9× 36 0.4× 111 1.6× 57 1.1× 26 0.5× 24 433
Meytal Liberman Israel 10 35 0.4× 138 1.5× 161 2.3× 60 1.1× 29 0.6× 20 415
Xiaoying Lei China 11 84 0.9× 16 0.2× 123 1.8× 33 0.6× 32 0.6× 22 348

Countries citing papers authored by William T. Clarke

Since Specialization
Citations

This map shows the geographic impact of William T. Clarke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William T. Clarke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William T. Clarke more than expected).

Fields of papers citing papers by William T. Clarke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William T. Clarke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William T. Clarke. The network helps show where William T. Clarke may publish in the future.

Co-authorship network of co-authors of William T. Clarke

This figure shows the co-authorship network connecting the top 25 collaborators of William T. Clarke. A scholar is included among the top collaborators of William T. Clarke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William T. Clarke. William T. Clarke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Feuerstein, Joseph D., Jonathan M. Erlich, Daniel J. Stein, et al.. (2020). Mo1808 CHROMOENDOSCOPY AND HIGH DEFINITION WHITE LIGHT COLONOSCOPY ARE EQUALLY EFFECTIVE TO SCREEN FOR COLON CANCER IN INFLAMMATORY BOWEL DISEASES: A RANDOMIZED CONTROL TRIAL PRELIMINARY ANALYSIS. Gastroenterology. 158(6). S–930. 4 indexed citations
2.
Papamichael, Konstantinos, William T. Clarke, Niels Vande Casteele, et al.. (2020). Comparison of Assays for Therapeutic Monitoring of Infliximab and Adalimumab in Patients With Inflammatory Bowel Diseases. Clinical Gastroenterology and Hepatology. 19(4). 839–841.e2. 18 indexed citations
3.
Clarke, William T., et al.. (2020). Antibiotic prophylaxis and infectious complications in patients on peritoneal dialysis undergoing lower gastrointestinal endoscopy. Gastroenterology report. 8(5). 407–409. 1 indexed citations
4.
Papamichael, Konstantinos, William T. Clarke, Sarah N. Flier, et al.. (2020). Clinical Impact of Corrections to Infliximab and Adalimumab Monitoring Results with the Homogeneous Mobility Shift Assay. Journal of Clinical Medicine. 9(9). 2840–2840. 2 indexed citations
5.
Clarke, William T., et al.. (2019). Metabolic syndrome and liver steatosis occur at lower body mass index in US Asian patients with chronic hepatitis B. Journal of Viral Hepatitis. 26(10). 1164–1169. 5 indexed citations
6.
Clarke, William T. & Joseph D. Feuerstein. (2019). Colorectal cancer surveillance in inflammatory bowel disease: Practice guidelines and recent developments. World Journal of Gastroenterology. 25(30). 4148–4157. 114 indexed citations
7.
Clarke, William T., Niels Vande Casteele, Joseph D. Feuerstein, et al.. (2019). Tu1830 – Infliximab and Adalimumab Concentrations May Vary Between the Enzyme-Linked Immunosorbent Assay and the Homogeneous Mobility Shift Assay in Patients with Inflammatory Bowel Disease. Gastroenterology. 156(6). S–1141. 2 indexed citations
9.
Clarke, William T. & Joseph D. Feuerstein. (2018). Updates in colorectal cancer screening in inflammatory bowel disease. Current Opinion in Gastroenterology. 34(4). 208–216. 14 indexed citations
10.
Clarke, William T., et al.. (2018). Sa1707 - Patients with Resolved HBV Infection (Anti-Hbc+, Hbsag-) on Anti-TNF Therapy have a Low Rate of Reactivation. Gastroenterology. 154(6). S–364. 1 indexed citations
11.
Rayner, Jennifer J., William T. Clarke, Mark A. Peterzan, et al.. (2017). P3331Obesity is associated with an increase in the forward rate constant of the creatine kinase reaction. European Heart Journal. 38(suppl_1). 1 indexed citations
12.
Zimmerman, David E., et al.. (2014). Comparison of free fraction serum valproic acid concentrations between inpatients and outpatients. American Journal of Health-System Pharmacy. 72(2). 121–126. 14 indexed citations
13.
Clarke, William T., Benjamin Edwards, Karl J. A. McCullagh, et al.. (2010). Syncoilin modulates peripherin filament networks and is necessary for large-calibre motor neurons. Journal of Cell Science. 123(15). 2543–2552. 24 indexed citations
14.
Clarke, William T. & Peter Marks. (2010). Gemtuzumab ozogamicin: is there room for salvage?. Blood. 116(14). 2618–2619. 18 indexed citations
15.
Edwards, Benjamin, Matthew Burgess, William T. Clarke, et al.. (2008). Syncoilin isoform organization and differential expression in murine striated muscle. Journal of Structural Biology. 165(3). 196–203. 10 indexed citations
16.
Bekker, Janine M., Andrew D. Stephens, William T. Clarke, et al.. (2007). Direct interaction of Gas11 with microtubules: Implications for the dynein regulatory complex. Cell Motility and the Cytoskeleton. 64(6). 461–473. 18 indexed citations
17.
Spitzer, Alan R., et al.. (1988). Pulmonary Hypertension and Persistent Fetal Circulation in the Newborn. Clinics in Perinatology. 15(2). 389–413. 26 indexed citations
18.
Fenton, Stanley S.A., York Pei, Terry Delmore, et al.. (1986). The CAPD Peritonitis Rate is Not Improving with Time. ASAIO Transactions. 32(1). 546–549. 8 indexed citations
19.
Hsu, Sara, et al.. (1986). Vaccination Against Schistosomiasis in Mice With Killed Schistosomula without Adjuvant. Experimental Biology and Medicine. 181(3). 454–458. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026